Androgens are the main regulator of normal human hair growth. After puberty, they promote transformation of vellus follicles, producing tiny, unpigmented hairs, to terminal ones, forming larger pigmented hairs, in many areas, e.g. the axilla. However, they have no apparent effect on the eyelashes, but can cause the opposite transformation on the scalp leading to the replacement of terminal hairs by vellus ones and the gradual onset of androgenetic alopecia. This paradox appears to be an unique hormonal effect. Hair follicles are mainly epithelial tissues, continuous with the epidermis, which project into the dermis. A mesenchyme-derived dermal papilla enclosed within the hair bulb at the base controls many aspects of follicle function. In the current hypothesis for androgen regulation, the dermal papilla is also considered the main site of androgen action with androgens from the blood binding to receptors in dermal papilla cells of androgen-sensitive follicles and causing an alteration of their production of paracrine factors for target cells e.g. keratinocytes. Studies of cultured dermal papilla cells from sites with different responses to androgens in vivo have confirmed the paradoxical responses. All dermal papilla cells from androgen-sensitive sites contain low capacity, high affinity androgen receptors. However, only some cells formed 5α-dihydrotestosterone, e.g. beard but not axillary cells, in line with hair growth in 5α-reductase deficiency. Incubation with androgens also stimulated the mitogenic capacity of beard cell media, but inhibited that produced by scalp cells. This suggests that the paradoxical differences are due to differential gene expression within hair follicles, presumably caused during embryogenesis.

Keywords:
Balding, Beard, Dermal papilla cells, Growth factors, Hair follicle, Human, Stem cell factor
1.
Randall VA: Androgens and human hair growth. Clin Endocrinol 1994;40:439–457.
2.
Marshall WA, Tanner JM: Variations in pattern of pubertal change in girls. Arch Dis Child 1969;44:291–303.
3.
Marshall WA, Tanner JM: Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970;45:13–23.
4.
Winter JSD, Faiman C: Pituitary-gonadal relations in male children and adolescents. Paed Res 1972;6:125–135.
5.
Winter JSD, Faiman C: Pituitary-gonadal relations in female children and adolescents. Paed Res 1973;7:948–953.
6.
Hamilton JB: Age, sex and genetic factors in the regulation of hair growth in man: A comparison of Caucasian and Japanese populations; in Montagna W, Ellis RA (eds): The Biology of Hair Growth. New York, Academic Press, 1958, pp 399–433.
7.
Randall VA: Androgens: The main regulator of human hair growth; in Camacho FM, Randall VA, Price VH (eds): Hair and Its Disorders: Biology, Pathology and Management. London, Martin Dunitz, 2000, pp 69–82.
8.
Hamilton JB: A secondary sexual character that develops in men but not in women upon ageing of an organ present in both sexes. Anat Record 1946;94:466–467.
9.
Hamilton JB: Patterned loss of hair in man; types and incidence. Ann NY Acad Sci 1951;53:708–728.
10.
Hamilton JB: Male hormone stimulation is a prerequisite and an incitant in common baldness. Amer J Anat 1942;71:451–480.
11.
Hamilton JB: Effect of castration in adolescent and young adult males upon further changes in the proportions of bare and hairy scalp. J Clin Endocrinol Metabol 1960;20:1309–1318.
12.
Randall VA: The biology of androgenetic alopecia; in Camacho FM, Randall VA, Price VH (eds): Hair and Its Disorders: Biology, Pathology and Management. London, Martin Dunitz, 2000, pp 123–136.
13.
Uno H, Imamura K, Pan Heui-ju: Androgenetic alopecia in the stump-tailed macaque: An important model for investigating the pathology and antiandrogenic therapy of male pattern baldness; in: Camacho FM, Randall VA, Price VH (eds): Hair and Its Disorders: Biology, Pathology and Management. London, Martin Dunitz, 2000, pp 137–151.
14.
Camacho FM, Randall VA, Price VH (eds): Hair and Its Disorders: Biology, Pathology and Management. London, Martin Dunitz, 2000.
15.
Wilson JD, Griffin JE, Russell DW: Steroid 5α-reductase 2 deficiency. Endocr Rev 1993;14:577–593.
16.
Randall VA: The role of 5α-reductase in health and disease; in Sheppard M, Stewart P (eds): Hormones, Enzymes and Receptors. Baillières Clin Endo Metabol 1994;8:405–431.
17.
Randall VA, Thornton MJ, Hamada K, Redfern CPF, Nutbrown M, Ebling FJG, Messenger AG: Androgens and the hair follicle: Cultured human dermal papilla cells as a model system. Ann NY Acad Sci 1991;642:355–375.
18.
Messenger AG: The culture of dermal papilla cells from human hair follicles. Br J Dermatol 1984;110:685–689.
19.
Randall VA, Hibberts NA, Hamada K: A comparison of the culture and growth of dermal papilla cells derived from normal and balding (androgentic alopecia) scalp. Br J Dermatol 1996;134:437–444.
20.
Jahoda CAB, Reynolds AJ: Dermal-epidermal interactions; adult follicle – derived cell populations and hair growth; in Whiting DA (ed): Dermatol Clin 14. Update on hair disorders. Saunders, Philadelphia, 1996, pp 573–583.
21.
Itami S, Kurata S, Takayasu S: Androgen induction of follicular epithelial cell growth is mediated via insulin-like growth factor I from dermal papilla cells. Biochem Biophys Res Commun 1995;212:988–994.
22.
Van Scott EJ, Ekel TM: Geometric relationships between the matrix of the hair bulb and its dermal papilla in normal and alopecic scalp. J Invest Dermatol 1958;31:281–287.
23.
Elliot K, Stephenson TJ, Messenger AG: Differences in hair follicle dermal papilla volume are due to extracellular matrix volume and cell number: Implications for the control of hair follicle size and androgen responses. J Invest Dermatol 1999;113:873–877.
24.
Randall VA, Hibberts NA, Thornton MJ, Merrick AE, Hamada K, Kato S, Jenner TJ, De Oliveira I, Messenger AG: Do androgens influence hair growth by altering the paracrine factors secreted by dermal papilla cells? Eur J Dermatol 2001; in press.
25.
Randall VA, Thornton MJ, Messenger AG: Cultured dermal papilla cells from androgen-dependent human follicles (e.g. beard) contain more androgen receptors than those from non-balding areas. J Endocrinol 1992;133:141–147.
26.
Hibberts NA, Howell AE, Randall VA: Dermal papilla cells from human balding scalp hair follicles contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol 1998;156:59–65.
27.
Itami S, Kurata S, Takayasu S: 5α-reductase activity in cultured human dermal papilla cells from beard compared with reticular dermal fibroblasts. J Invest Dermatol 1990;94:150–152.
28.
Thornton MJ, Liang I, Hamada K, Messenger AG, Randall VA: Differences in testosterone metabolism by beard and scalp hair follicle dermal papilla cells. Clin Endocrinol 1993;39:633–639.
29.
Hamada K, Thornton MJ, Liang I, Messenger AG, Randall VA: The metabolism of testosterone by dermal papilla cells cultured from human pubic and axillary hair follicles concurs with hair growth in 5α-reductase deficiency. J Invest Dermatol 1996;106:1017–1022.
30.
Hamada K, Randall VA: The metabolism of testosterone by dermal papilla cells cultured from scalp follicles of men with androgenetic alopecia. J Invest Derm 1993;101:440.
31.
Kaufman KD, Olsen EA, Whiting D, Savi R, De Villez R, Bergfeld W and the Finasteride Male Pattern Hair Loss Study Group: Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1988;39:578–589.
32.
Price VH: Clinical trials of oral finasteride; in Camacho FM, Randall VA, Price VH (eds): Hair and Its Disorders: Biology, Pathology and Management. London, Martin Dunitz, 2000, pp 159–166.
33.
Stenn KS, Combates NJ, Eilertson KJ, Gordon JS, Poardinas JR, Parimoo S, Prouty S: Hair follicle growth controls; in Whiting DA (ed): Dermatol Clin 14. Update on hair disorders. Saunders, Philadelphia, 1996, pp 543–558.
34.
Blume-Peytavi, U Mandt N. Signalling molecules in human hair follicle cell populations; in Camacho FM, Randall VA, Price VH (eds): Hair and Its Disorders: Biology, Pathology and Management. London, Martin Dunitz, 2000, pp 95–101.
35.
Philpott M: The roles of growth factors in hair follicles: investigations using cultured hair follicles; in Camacho FM, Randall VA, Price VH (eds): Hair and Its Disorders: Biology, Pathology and Management. London, Martin Dunitz, 2000, pp 103–113.
36.
Paus R, Müller-Röver S, McKay I: Control of the hair follicle growth cycle; in Camacho FM, Randall VA, Price VH (eds): Hair and its Disorders: Biology, Pathology and Management. London, Martin Dunitz, 2000 pp 83–94.
37.
Thornton MJ, Hamada K, Messenger AG, Randall VA: Beard, but not scalp, dermal papilla cells secrete autocrine growth factors in response to testosterone in vitro. J Invest Dermatol 1998;111:727–732.
38.
Hibberts NA, Quick JR, Messenger AG, Randall VA: Only androgen-dependent cultured dermal papilla cells secrete additional proteinaceous factors mitogenic for keratinocytes in response to testosterone. Br J Dermatol 1994;131:427.
39.
Hibberts NA, Sato K, Messenger AG, Randall VA: Dermal papilla cells from human hair follicles secrete factors (e.g. VEGF) mitrogenic for endothelial cells. J Invest Dermatol 1996;106:341.
40.
Merrick AE, Hibberts NA, Messenger AG, Thornton MJ, Randall VA: Balding dermal papilla cells from human hair follicles express less hepatocyte growth factor (HGF) than normal scalp and beard cells. 7th European Hair Res Soc 2000.
41.
Hibberts NA, Messenger AG, Randall VA: Dermal papilla cells derived from beard hair follicles secrete more stem cell factor (SCF) in culture than scalp cells or dermal fibroblasts. Biochem Biophys Res Commun 1996;222:401–405.
42.
Williams DE, de Vries P, Namen AE, Widmer MB, Lyman SD: The steel factor. Dev Biol 1992;151:368–376.
43.
Grichnik JM, Burch JA, Burchette J, Shea CR: The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. J Invest Dermatol 1998;111:233–238.
44.
Geissler EN, Cheng SV, Gusella JF, Housmann D: The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 1988;55:185–192.
45.
Fleischman RA, Saltman DL, Stastry V, Zneimer S: Deletion of the c-kit proto-oncogene in the human developmental defect piebald trait. Proc Natl Acad Sci 1991;88:10885–10889.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.